Hjem › Kardiovaskulær sygdom › Oklahoma
Kardiovaskulær sygdom kliniske forsøg i Oklahoma
11 studier for Kardiovaskulær sygdom søger deltagere på steder i Oklahoma.
Byer i Oklahoma
Officiel studietekst (engelsk)
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- Oklahoma Heart Institute, Tulsa
Rekrutterer
Alder 18 til 85 · Alle køn · Opdateret 1. okt. 2026 · NCT07214376EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Tekton Research Oklahoma City, Oklahoma City
- South Oklahoma Heart Research Group, Oklahoma City
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07064473Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- South Oklahoma Heart Research, LLC, Oklahoma City
RekruttererFase 4
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT06909565Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Edmond
- Clinical Trial Site, Moore
- Clinical Trial Site, Norman
- og 1 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT07181109Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
- Integris Baptist Medical Center, Oklahoma City
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT03242642A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Oklahoma City
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. aug. 2026 · NCT07000357OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Alliance for Multispecialty Research, Norman
RekruttererFase 3
Alder 50 til 105 · Alle køn · Opdateret 21. aug. 2026 · NCT07136012Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Integris Baptist Medical Center, Oklahoma City
- Oklahoma Heart Institute at Utica, Tulsa
- Saint Francis Hospital, Tulsa
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 10. jun. 2026 · NCT06526195The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- Oklahoma Heart Institute Hospital, Tulsa
- Saint Francis Hospital,, Tulsa
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 13. apr. 2026 · NCT03142152MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
- University of Oklahoma Health Science Center, Oklahoma City
Rekrutterer
Alder 18 til 80 · Alle køn · Opdateret 11. sep. 2025 · NCT06271590MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
- Oklahoma University Health (OU Health), Oklahoma City
Rekrutterer
Alder 18 til 110 · Alle køn · Opdateret 25. feb. 2025 · NCT05908331Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.